Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The role of therapeutic drug monitoring in individualizing immunosuppressive drug therapy: recent developments.

× No keyword cloud information.

13 in total

1. Comparison between a liquid chromatography-tandem mass spectrometry assay and a fluorescent polarization immunoassay to measure whole blood everolimus concentration in heart and renal transplantations.

Authors: Eric Dailly; G Deslandes; M Hourmant; T Petit; C Renaud; M Treilhaud; P Jolliet
Journal: J Clin Lab Anal Date: 2008 Impact factor: 2.352

Review 2. Pharmacokinetic optimization of immunosuppressive therapy in thoracic transplantation: part II.

Authors: Caroline Monchaud; Pierre Marquet
Journal: Clin Pharmacokinet Date: 2009 Impact factor: 6.447

Review 3. Pharmacokinetic optimization of immunosuppressive therapy in thoracic transplantation: part I.

Authors: Caroline Monchaud; Pierre Marquet
Journal: Clin Pharmacokinet Date: 2009 Impact factor: 6.447

Review 4. Dosage individualization in children: integration of pharmacometrics in clinical practice.

Authors: Wei Zhao; Stéphanie Leroux; Evelyne Jacqz-Aigrain
Journal: World J Pediatr Date: 2014-08-15 Impact factor: 2.764

5. Pharmacodynamic assessment of ex-vivo canine T-lymphocyte proliferation: Responses to dexamethasone, cyclosporine, mycophenolic acid, and the active metabolite of leflunomide.

Authors: Megan Grobman; Kaitlin A Bishop; Hansjorg Rindt; Laura A Nafe; Carol R Reinero
Journal: Can J Vet Res Date: 2019-10 Impact factor: 1.310

Review 6. Pharmacokinetics, Pharmacodynamics, and Pharmacogenomics of Immunosuppressants in Allogeneic Hematopoietic Cell Transplantation: Part II.

Authors: Jeannine S McCune; Meagan J Bemer; Janel Long-Boyle
Journal: Clin Pharmacokinet Date: 2016-05 Impact factor: 6.447

7. A Limited Sampling Strategy to Estimate Exposure of Everolimus in Whole Blood and Peripheral Blood Mononuclear Cells in Renal Transplant Recipients Using Population Pharmacokinetic Modeling and Bayesian Estimators.

Authors: Ida Robertsen; Jean Debord; Anders Åsberg; Pierre Marquet; Jean-Baptiste Woillard
Journal: Clin Pharmacokinet Date: 2018-11 Impact factor: 6.447

8. A rapid HPLC-MS/MS method for the simultaneous quantification of cyclosporine A, tacrolimus, sirolimus and everolimus in human blood samples.

Authors: Christoph Seger; Karin Tentschert; Wolfgang Stöggl; Andrea Griesmacher; Steven L Ramsay
Journal: Nat Protoc Date: 2009 Impact factor: 13.491

9. Blood and plasma pharmacokinetics of ciclosporin in diabetic kidney transplant recipients.

Authors: Anisha E Mendonza; Reginald Y Gohh; Fatemeh Akhlaghi
Journal: Clin Pharmacokinet Date: 2008 Impact factor: 6.447

10. Neoimmun versus Neoral: a bioequivalence study in healthy volunteers and influence of a fat-rich meal on the bioavailability of Neoimmun.

Authors: F Kees; M Bucher; F Schweda; H Gschaidmeier; L Faerber; R Seifert
Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 2007-06-15 Impact factor: 3.195